Friday 25 March 2011

Propofol B.Braun




Propofol B.Braun may be available in the countries listed below.


Ingredient matches for Propofol B.Braun



Propofol

Propofol is reported as an ingredient of Propofol B.Braun in the following countries:


  • Denmark

  • Italy

International Drug Name Search

Thursday 24 March 2011

Novosta




Novosta may be available in the countries listed below.


Ingredient matches for Novosta



Aspirin

Acetylsalicylic Acid is reported as an ingredient of Novosta in the following countries:


  • Indonesia

Pravastatin

Pravastatin sodium salt (a derivative of Pravastatin) is reported as an ingredient of Novosta in the following countries:


  • Indonesia

International Drug Name Search

Tuesday 22 March 2011

danazol


Generic Name: danazol (DAN a zol)

Brand Names: Danocrine


What is danazol?

Danazol is a man-made form of a steroid. Danazol affects the ovaries and pituitary gland and prevents the release of certain hormones in the body.


Danazol is used to treat endometriosis and fibrocystic breast disease. Danazol is also used to prevent attacks of angioedema in people with an inherited form of this disorder.


Danazol may also be used for other purposes not listed in this medication guide.


What is the most important information I should know about danazol?


You should not use this medication if you are allergic to danazol, or if you have porphyria, or severe problems with your heart, liver, or kidney. You also should not take danazol if you are pregnant or breast-feeding, or if you have abnormal vaginal bleeding that has not been checked by a doctor. This medication can cause birth defects. Do not use if you are pregnant.

Before you start taking danazol, you may need to have a pregnancy test to make sure you are not pregnant.


Use an effective barrier form of birth control (such as a condom or diaphragm with spermicide gel or inserts). Hormonal forms of contraception (such as birth control pills, injections, implants, skin patches, and vaginal rings) may not be effective enough to prevent pregnancy during your treatment.

Your medication needs may change if you have unusual stress such as a serious illness, fever or infection, or if you have surgery or a medical emergency. Tell your doctor about any such situation that affects you.


Call your doctor at once if you have a serious side effect such as sudden numbness or weakness, problems with vision or speech, chest pain, sudden cough, or wheezing, swelling, rapid weight gain, feeling short of breath, ringing in your ears, dizziness, nausea, pain behind your eyes, stomach pain and loss of appetite, dark urine, or jaundice (yellowing of the skin or eyes).

What should I discuss with my healthcare provider before taking danazol?


You should not use this medication if you are allergic to danazol, or if you have:

  • severe heart disease;




  • severe kidney disease;




  • severe liver disease;




  • porphyria;




  • abnormal vaginal bleeding that has not been checked by a doctor;



  • if you are pregnant or breast-feeding a baby.

Before taking danazol, tell your doctor if you are allergic to any drugs, or if you have:



  • a history of stroke or blood clot;




  • high cholesterol or triglycerides, coronary artery disease;




  • breast cancer;




  • a seizure disorder;




  • heart disease, congestive heart failure;




  • kidney or liver disease; or




  • migraine headaches.



If you have any of these conditions, you may need a dose adjustment or special tests to safely take danazol.


FDA pregnancy category X. This medication can cause birth defects. Do not use danazol if you are pregnant. Tell your doctor right away if you become pregnant during treatment.

Before you start taking danazol, you may need to have a pregnancy test to make sure you are not pregnant.


Use an effective barrier form of birth control (such as a condom or diaphragm with spermicide gel or inserts). Hormonal forms of contraception (such as birth control pills, injections, implants, skin patches, and vaginal rings) may not be effective enough to prevent pregnancy during your treatment.

Taking danazol to treat endometriosis may increase your risk of ovarian cancer. Talk with your doctor about your individual risk.


How should I take danazol?


Take this medication exactly as it was prescribed for you. Do not take the medication in larger amounts, or take it for longer than recommended by your doctor. Follow the directions on your prescription label.


Women who take danazol may need to start the medication during a menstrual period. Follow your doctor's instructions.

Your doctor may occasionally change your dose to make sure you get the best results from this medication.


Your medication needs may change if you have unusual stress such as a serious illness, fever or infection, or if you have surgery or a medical emergency. Tell your doctor about any such situation that affects you.


This medication can cause you to have unusual results with certain medical tests. Tell any doctor who treats you that you are using danazol.


It may take several weeks of using this medicine before your symptoms improve. For best results, keep using the medication as directed. Get your prescription refilled before you run out of medicine completely.

Talk with your doctor if your symptoms do not improve after 2 months of taking danazol, or if you continue to have attacks of angioedema.


Store danazol at room temperature away from moisture and heat.

See also: Danazol dosage (in more detail)

What happens if I miss a dose?


Take the missed dose as soon as you remember. If it is almost time for your next dose, wait until then to take the medicine and skip the missed dose. Do not take extra medicine to make up the missed dose.


Call your doctor for instructions if you have missed doses for more than 2 days in a row.

What happens if I overdose?


Seek emergency medical attention if you think you have received too much of this medicine.

A single large dose of danazol is not expected to produce life-threatening symptoms. However, high doses taken over a long period of time may cause weight gain, increased acne or facial hair growth, menstrual problems, or breast changes.


What should I avoid while taking danazol?


Follow your doctor's instructions about any restrictions on food, beverages, or activity while you are using danazol.


Danazol side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Call your doctor at once if you have any of these serious side effects:

  • sudden numbness or weakness, confusion, problems with vision, speech, or balance;




  • chest pain, sudden cough, wheezing, rapid breathing, fast heart rate;




  • swelling, rapid weight gain, feeling short of breath;




  • headache, ringing in your ears, dizziness, nausea, vision problems, pain behind your eyes; or




  • stomach pain, loss of appetite, dark urine, jaundice (yellowing of the skin or eyes).



Less serious side effects may include:



  • acne or other skin problems;




  • increased hair growth or hair loss;




  • weight gain;




  • breast changes;




  • deepened voice;




  • nervousness;




  • increased sweating, warmth or tingly feeling under your skin;




  • changes in your menstrual periods; or




  • vaginal dryness, discomfort, or itching.



This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.


Danazol Dosing Information


Usual Adult Dose for Endometriosis:

100 mg to 200 mg orally two times a day.

Severe cases of endometriosis may require an initial dosage of 400 mg orally two times a day.

To assure that the patient is not pregnant, therapy should be initiated during menstruation. If this is not possible, a sensitive pregnancy test that detects early pregnancy should be done to insure the patient is not pregnant. A non-hormonal birth control method is recommended.

Following an initial favorable response (amenorrhea develops), the dosage should be titrated to the minimum dose that suppresses disease activity.

Therapy should continue uninterrupted for 3 to 6 months. Administration of danazol up to 9 months may be necessary. Should symptoms recur, danazol treatment may be reinitiated.

Usual Adult Dose for Fibrocystic Breast Disease:

50 mg to 200 mg orally two times a day.

To assure that the patient is not pregnant, therapy should be initiated during menstruation. If this is not possible, a sensitive pregnancy test that detects early pregnancy should be done to insure the patient is not pregnant. A non- hormonal birth control method is recommended.

Resolution of pain and tenderness usually occurs following 1 to 3 months of therapy. Elimination of nodules often requires 4 to 6 months of uninterrupted therapy. Symptoms recur within one year in 50% of patients and therapy may be reinitiated if necessary.

Usual Adult Dose for Angioedema:

200 mg orally two to three times a day.

To assure a female patient is not pregnant, therapy should be initiated during menstruation. If this is not possible, a sensitive pregnancy test that detects early pregnancy should be done to insure the patient is not pregnant. A non- hormonal birth control method is recommended.

Following an initial favorable response (prevention of edematous episodes), attempts should be made at 1 to 3 month intervals to reduce the dosage to the minimum continuous dose that will prevent angioedema. Dosage reductions up to 50% per interval may be considered. Should angioedema recur, the daily dosage may be increased up to 200 mg.


What other drugs will affect danazol?


Before taking danazol, tell your doctor if you are taking:



  • a blood thinner such as warfarin (Coumadin); or




  • carbamazepine (Carbatrol, Tegretol).



This list is not complete and there may be other drugs that can interact with danazol. Tell your doctor about all the prescription and over-the-counter medications you use. This includes vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start using a new medication without telling your doctor.



More danazol resources


  • Danazol Side Effects (in more detail)
  • Danazol Dosage
  • Danazol Use in Pregnancy & Breastfeeding
  • Drug Images
  • Danazol Drug Interactions
  • Danazol Support Group
  • 3 Reviews for Danazol - Add your own review/rating


  • danazol Advanced Consumer (Micromedex) - Includes Dosage Information

  • Danazol Prescribing Information (FDA)

  • Danazol Professional Patient Advice (Wolters Kluwer)

  • Danazol Monograph (AHFS DI)

  • Danazol MedFacts Consumer Leaflet (Wolters Kluwer)

  • Danocrine Prescribing Information (FDA)



Compare danazol with other medications


  • Angioedema
  • Endometriosis
  • Evan's Syndrome
  • Fibrocystic Breast Disease


Where can I get more information?


  • Your pharmacist can provide more information about danazol.

See also: danazol side effects (in more detail)


Thursday 17 March 2011

Locoid Lipocream


See also: Generic Locoid


Locoid Lipocream is a brand name of hydrocortisone topical, approved by the FDA in the following formulation(s):


LOCOID LIPOCREAM (hydrocortisone butyrate - cream; topical)



  • Manufacturer: TRIAX PHARMS LLC

    Approval date: September 8, 1997

    Strength(s): 0.1% [RLD]

Has a generic version of Locoid Lipocream been approved?


No. There is currently no therapeutically equivalent version of Locoid Lipocream available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Locoid Lipocream. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Topical application compositions
    Patent 5,635,497
    Issued: June 3, 1997
    Inventor(s): Molenaar; Adrianus P.
    Assignee(s): Yamanouchi Europe B.V.
    A stable topical application composition in the form of a fatty cream comprising 50 to 80% by weight of fatty components, 1.5 to 5% by weight of at least one hydrophilic non-ionic surfactant, a therapeutically effective amount of at least one topically active therapeutic agent and water and a novel method of administering a topically active therapeutic agent.
    Patent expiration dates:

    • June 3, 2014



Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • October 19, 2012 - MILD TO MODERATE ATOPIC DERMATITIS IN PATIENTS 3 MONTHS OF AGE TO LESS THAN 18 YEARS OF AGE

See also...

  • Locoid Lipocream Consumer Information (Cerner Multum)
  • Locoid Lipocream Advanced Consumer Information (Micromedex)
  • Locoid Lipocream Topical application Advanced Consumer Information (Micromedex)
  • Hemorrhoidal-HC Suppositories Consumer Information (Wolters Kluwer)
  • Hydrocortisone Acetate Suppositories Consumer Information (Wolters Kluwer)
  • Hydrocortisone Butyrate Solution Consumer Information (Wolters Kluwer)
  • Hydrocortisone Cream Consumer Information (Wolters Kluwer)
  • Hydrocortisone Foam Consumer Information (Wolters Kluwer)
  • Hydrocortisone Gel Consumer Information (Wolters Kluwer)
  • Hydrocortisone Lotion Consumer Information (Wolters Kluwer)
  • Hydrocortisone rectal cream, ointment, suppository Consumer Information (Cerner Multum)
  • Hydrocortisone topical Consumer Information (Cerner Multum)
  • Anusol HC Advanced Consumer Information (Micromedex)
  • Barriere-Hc Topical application Advanced Consumer Information (Micromedex)
  • Cort-Eze Topical application Advanced Consumer Information (Micromedex)
  • Corta-Cap Advanced Consumer Information (Micromedex)
  • Cortagel Extra Strength Advanced Consumer Information (Micromedex)
  • Cortate Topical application Advanced Consumer Information (Micromedex)
  • Corticool Maximum Strength Advanced Consumer Information (Micromedex)
  • Cortoderm Mild Ointment Topical application Advanced Consumer Information (Micromedex)
  • Cortoderm Regular Ointment Topical application Advanced Consumer Information (Micromedex)
  • Delacort Advanced Consumer Information (Micromedex)
  • Dermarest Advanced Consumer Information (Micromedex)
  • Emo-Cort Scalp Solution Topical application Advanced Consumer Information (Micromedex)
  • Emo-Cort Topical application Advanced Consumer Information (Micromedex)
  • Foille Cort Advanced Consumer Information (Micromedex)
  • Hydrocortisone Cream Topical application Advanced Consumer Information (Micromedex)
  • Hydroval Advanced Consumer Information (Micromedex)
  • Hydrozone Plus Advanced Consumer Information (Micromedex)
  • Instacort-10 Advanced Consumer Information (Micromedex)
  • Ivy Soothe Advanced Consumer Information (Micromedex)
  • IvyStat Advanced Consumer Information (Micromedex)
  • Keratol HC Advanced Consumer Information (Micromedex)
  • Kericort 10 Advanced Consumer Information (Micromedex)
  • Medi-Cortisone Maximum Strength Advanced Consumer Information (Micromedex)
  • Microcort Advanced Consumer Information (Micromedex)
  • Mycin Scalp Advanced Consumer Information (Micromedex)
  • Neutrogena T/Scalp Advanced Consumer Information (Micromedex)
  • Novo-Hydrocort Cream Topical application Advanced Consumer Information (Micromedex)
  • Novo-Hydrocort Topical application Advanced Consumer Information (Micromedex)
  • NuCort Advanced Consumer Information (Micromedex)
  • Nupercainal HC Advanced Consumer Information (Micromedex)
  • Pediaderm HC Kit Advanced Consumer Information (Micromedex)
  • Prevex Hc Topical application Advanced Consumer Information (Micromedex)
  • Sarna Hc Topical application Advanced Consumer Information (Micromedex)
  • Sarnol-HC Maximum Strength Advanced Consumer Information (Micromedex)
  • Summer's Eve Specialcare Advanced Consumer Information (Micromedex)
  • Tarocort Advanced Consumer Information (Micromedex)
  • Therasoft Anti-Itch & Dermatitis Advanced Consumer Information (Micromedex)
  • Hydrocortisone Topical application Advanced Consumer Information (Micromedex)
  • Hydrocortisone butyrate Topical application Advanced Consumer Information (Micromedex)
  • Hydrocortisone probutate Topical application Advanced Consumer Information (Micromedex)
  • Hydrocortisone valerate Topical application Advanced Consumer Information (Micromedex)
  • Hydrocortisone Acetate topical AHFS DI Monographs (ASHP)
  • Hydrocortisone Buteprate topical AHFS DI Monographs (ASHP)
  • Hydrocortisone Butyrate topical AHFS DI Monographs (ASHP)
  • Hydrocortisone Valerate topical AHFS DI Monographs (ASHP)
  • Hydrocortisone topical AHFS DI Monographs (ASHP)

Friday 11 March 2011

Emalook




Emalook may be available in the countries listed below.


Ingredient matches for Emalook



Tamoxifen

Tamoxifen citrate (a derivative of Tamoxifen) is reported as an ingredient of Emalook in the following countries:


  • Japan

International Drug Name Search

Wednesday 9 March 2011

Flurazepam ratiopharm




Flurazepam ratiopharm may be available in the countries listed below.


Ingredient matches for Flurazepam ratiopharm



Flurazepam

Flurazepam monohydrochloride (a derivative of Flurazepam) is reported as an ingredient of Flurazepam ratiopharm in the following countries:


  • Netherlands

International Drug Name Search

TSH Suppression Medications


Drugs associated with TSH Suppression

The following drugs and medications are in some way related to, or used in the treatment of TSH Suppression. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.





Drug List:

Monday 7 March 2011

Amiodarone Almus




Amiodarone Almus may be available in the countries listed below.


Ingredient matches for Amiodarone Almus



Amiodarone

Amiodarone hydrochloride (a derivative of Amiodarone) is reported as an ingredient of Amiodarone Almus in the following countries:


  • France

International Drug Name Search

Sunday 6 March 2011

Telnase




Telnase may be available in the countries listed below.


Ingredient matches for Telnase



Triamcinolone

Triamcinolone 16α,17α-acetonide (a derivative of Triamcinolone) is reported as an ingredient of Telnase in the following countries:


  • Australia

  • New Zealand

International Drug Name Search